Catalyst Wire Dossier Catalyst Wire Dossier

Biphasic Remogliflozin Etabonate

remogliflozin etabonate · BHV Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biphasic Remogliflozin Etabonate, covering 2018-01-18 to 2018-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes [Phase 2]

See pricing